For research use only. We do not sell to patients.
Vimseltinib
CAS No. : 1628606-05-2
Biological Activity：Vimseltinib (DCC-3014) is a c-FMS (CSF-IR) and c-Kit dual inhibitor extracted from patent WO2014145025A2, Compound Example 10, has IC50s of <0.01 μM and 0.1-1 μM, respectively.
Research Area：Cancer
Targets：c-Kit|c-Fms
Related Screening Libraries:Drug Repurposing Compound Library Plus;Clinical Compound Library Plus;Bioactive Compound Library Plus;Kinase Inhibitor Library;Protein Tyrosine Kinase Compound Library;Anti-Cancer Compound Library;Clinical Compound Library;Drug Repurposing Compound Library;Anti-Blood Cancer Compound Library;Anti-Liver Cancer Compound Library ;
Related Small Molecules:Henatinib;c-Kit-IN-5-1;Flumatinib mesylate;IHMT-TRK-284;Chiauranib;Pexidartinib;AZD2932;GW2580-d6;Tandutinib;CSF1R-IN-1;BPR1R024;Avapritinib;PF 477736;Masitinib;SU14813 maleate;HG-7-85-01;CHMFL-ABL/KIT-155;GENZ-882706(Raceme);VEGFR-IN-1;c-Fms-IN-7;M4205
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
- Structurally and synthetically diverse biologically active compounds；
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；
- Customized order volume ranging from milligrams to kilograms scale；
Structurally and synthetically diverse biologically active compounds；
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.
